Question 1

Does Franklin Templeton own NGNE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Franklin Templeton holds 204,280 shares of NGNE (Neurogene), worth $6.4M.

Question 2

How many shares of NGNE does Franklin Templeton own?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton holds 204,280 shares of NGNE (Neurogene).

Question 3

What is Franklin Templeton's NGNE position worth?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton's NGNE position is worth $6.4M.

Question 4

Is Franklin Templeton buying or selling NGNE?

Accepted Answer

In Q2 2026, Franklin Templeton opened a new NGNE position of 204,280 shares.

Question 5

When did Franklin Templeton first buy NGNE?

Accepted Answer

Franklin Templeton first reported NGNE in its Q3 2024 13F and has listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	204,280	-	$6.4M	0.0%	$31.45	38
2024-Q4	Exited	0	-100.0%	$0	0.0%	$22.28	0
2024-Q3	New	7,050	-	$350,738	0.0%	$40.33	33

NGNE3 quarters

NGNE
3 quarters